REG - Craneware plc - Blocklisting Application

CranewareAnnouncement

20/03/2020 09:00

RNS Number : 9714G
  
Craneware plc
  
20 March 2020
  
 

 
Craneware plc
("Craneware" or the "Company")
 
 
Blocklisting Application
 
Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that a block listing application has been made to the London Stock Exchange for 350,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission").  The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options and vested awards pursuant to the terms of the following share plans:
 



Share plan


Number of Ordinary Shares




The Craneware plc Schedule 4 Company Share Option Plan (2016)


50,000




The Craneware plc Unapproved Company Share Option Plan (2016)


200,000




The Craneware plc Long Term Incentive Plan (2016)


100,000














Total


350,000



 
 
It is expected that Admission of these Ordinary Shares will become effective on 23 March 2020. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares. 
 
 
 
 For further information, please contact:



Craneware plc


Peel Hunt


Investec Bank 


Alma 








(NOMAD & Joint Broker)


(Joint Broker)


(Financial PR)




+44 (0)131 550 3100


+44 (0)20 7418 8900


+44 (0)20 7597 5970


+44 (0)203 405 0205




Keith Neilson, CEO


Dan Webster 


Patrick Robb


Caroline Forde 




Craig Preston, CFO


George Sellar


Sebastian Lawrence


Hilary Buchanan








Andrew Clark


Henry Reast


Helena Bogle



 
About Craneware
 
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions. 
 
Learn more at www.craneware.com 
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ALSPPUWAWUPUUMU